SCHRODER INVESTMENT MANAGEMENT GROUP
Position in AUTL — Autolus Therapeutics plc
CIK 1086619
London, X0
Position in AUTL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$12,533,251
-$562,045 QoQ
Shares Held
7,833,282
-17.5% QoQ
Ownership
2.94%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#6
of 84 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AUTL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SCHRODER INVESTMENT MANAGEMENT GROUP holds $692,439,062 across 60 Biotechnology names. AUTL ranks #16 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
1,410,943 | $99,683,122 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
169,270 | $84,081,485 | |
| 3 | EXEL |
Exelixis, Inc.
|
669,005 | $36,400,560 | |
| 4 | INSM |
INSMED Inc
|
298,372 | $31,812,422 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
95,194 | $28,656,248 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
51,630 | $27,722,728 | |
| 7 | VERA |
Vera Therapeutics, Inc.
|
510,787 | $21,917,869 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
379,611 | $21,565,700 |
All Filings in AUTL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,533,251 | 7,833,282 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $13,095,296 | 9,489,345 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $18,883,796 | 9,489,345 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $13,746,202 | 8,433,253 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $8,227,357 | 3,608,490 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,593,159 | 3,608,490 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $6,731,885 | 2,864,632 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $10,398,614 | 2,864,632 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $8,533,099 | 2,452,040 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $10,672,030 | 1,672,732 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $10,772,394 | 1,672,732 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,897,465 | 1,672,732 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,981,102 | 1,672,732 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,077,826 | 1,672,732 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,178,190 | 1,672,732 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $3,579,646 | 1,672,732 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,733,831 | 1,672,732 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $6,975,292 | 1,672,732 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $8,681,479 | 1,672,732 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $10,956,394 | 1,672,732 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $11,106,940 | 1,672,732 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $9,584,754 | 1,672,732 | Shares | Sole | 2021-05-28 | |
| 2020-12-31 | $14,954,224 | 1,672,732 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $18,224,166 | 1,565,650 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $28,627,239 | 1,785,854 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $12,549,810 | 2,095,127 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||